SCHEMBL7829757

SCHEMBL7829757

[CH2]C(=O)NCC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1934297 0.74
SCHEMBL1656918 0.74
SCHEMBL21680800 0.74
SCHEMBL7823923 0.74
SCHEMBL4400430 0.72
SCHEMBL7876647 0.72
SCHEMBL10631585 0.72 MCL1 (0.46)
SCHEMBL3372799 0.72
SCHEMBL245262 0.72
SCHEMBL1460677 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111295376-B Injectable isoxazoline pharmaceutical composition and use thereof against parasite infestations 英特维特国际股份有限公司 2024-05-24 CN claimed
EP-4358941-A1 PALATABLE VETERINARY COMPOSITIONS Intervet International B.V. (NL) 2024-05-01 EP claimed
US-20240122849-A1 ISOXAZOLINE COMPOSITIONS AND USE THEREOF IN THE PREVENTION OR TREATMENT OF PARASITE INFESTATIONS IN ANIMALS INTERVET INC. (US) 2024-04-18 US claimed
EP-4351341-A1 TICK CONTROL METHODS Intervet International B.V. (NL) 2024-04-17 EP claimed
CN-117545473-A Palatable veterinary compositions 英特维特国际股份有限公司 2024-02-09 CN claimed
EP-4316522-A2 INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE AGAINST PARASITE INFESTATION Intervet International B.V. (NL) 2024-02-07 EP claimed
EP-4306168-A2 ISOXAZOLINE COMPOSITIONS AND USE THEREOF IN THE PREVENTION OR TREATMENT OF PARASITE INFESTATIONS IN ANIMALS Intervet International B.V. (NL) 2024-01-17 EP claimed
EP-4076447-B1 PARASITE CONTROL IN RUMINANTS INTERVET INT BV (NL) 2024-01-17 EP claimed
EP-3082867-B1 ISOXAZOLINE COMPOSITIONS AND USE THEREOF IN THE PREVENTION OR TREATMENT OF PARASITE INFESTATIONS IN ANIMALS INTERVET INT BV (NL) 2024-01-17 EP claimed
EP-3707128-B1 INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE AGAINST PARASITE INFESTATION INTERVET INT BV (NL) 2023-12-20 EP claimed
WO-2014079825-A1 MANUFACTURING OF SEMI-PLASTIC PHARMACEUTICAL DOSAGE UNITS INTERVET INTERNATIONAL B.V. (NL) 2014-05-30 WO claimed
US-20140141055-A1 MANUFACTURING OF SEMI-PLASTIC PHARMACEUTICAL DOSAGE UNITS INTERVET INC. 2014-05-22 US claimed
EP-2658542-A2 TOPICAL LOCALIZED ISOXAZOLINE FORMULATION Intervet International B.V. (NL) 2013-11-06 EP claimed
EP-2658541-A1 TOPICAL LOCALIZED ISOXAZOLINE FORMULATION COMPRISING GLYCOFUROL Intervet International B.V. (NL) 2013-11-06 EP claimed
US-20130281501-A1 TOPICAL LOCALIZED ISOXAZOLINE FORMULATION INTERVET INC. 2013-10-24 US claimed
US-20130274302-A1 TOPICAL LOCALIZED ISOXAZOLINE FORMULATION COMPRISING GLYCOFUROL INTERVET INC. 2013-10-17 US claimed
WO-2013150052-A1 SOFT CHEWABLE PHARMACEUTICAL PRODUCTS INTERVET INTERNATIONAL B.V. (NL) 2013-10-10 WO claimed
WO-2013150055-A1 SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS INTERVET INTERNATIONAL B.V. (NL) 2013-10-10 WO claimed
WO-2012089622-A2 TOPICAL LOCALIZED ISOXAZOLINE FORMULATION INTERVET INTERNATIONAL B.V. (NL) 2012-07-05 WO claimed
WO-2012089623-A1 TOPICAL LOCALIZED ISOXAZOLINE FORMULATION COMPRISING GLYCOFUROL INTERVET INTERNATIONAL B.V. (NL) 2012-07-05 WO claimed